NCT06797999
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06797999
Title First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma (ADCElerate1)
Acronym ADCElerate1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Adcendo ApS
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | DEU | BEL


No variant requirements are available.